Top compounds associated with response to DPY30


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.04
mRNA CCT007093 GDSC1000 pan-cancer AAC -0.078 0.04
mRNA SN-38 GDSC1000 pan-cancer AAC 0.075 0.04
mRNA MPS-1-IN-1 GDSC1000 pan-cancer AAC 0.072 0.04
mRNA GSK-1904529A GDSC1000 pan-cancer AAC -0.075 0.04
mRNA BRD-K16147474 CTRPv2 pan-cancer AAC -0.085 0.05
mRNA L-685458 CCLE pan-cancer AAC -0.098 0.05
mRNA linifanib GDSC1000 pan-cancer AAC -0.076 0.05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.05
mRNA QS11 GDSC1000 pan-cancer AAC -0.076 0.05
Download CSV